AI Readiness Assessment for Medical Device Manufacturers: Why FDA Audit Risk Starts in Your M365 Tenant
June 24, 2026
An FDA inspector will not walk into your facility and ask to review your theoretical corporate position on artificial intelligence. Instead, they will ask to see your data governance documentation, your electronic signature records, your access control logs, and your continuous audit trails. If your team has already deployed automated intelligence or cognitive agents without setting up these technical guardrails, the inspection will find the compliance gap immediately. The inspector doesn’t need to hunt for the AI; they simply follow the messy data trail it leaves behind.
At Cocha Technology, my partner Steve and I frequently look under the hood of highly regulated manufacturing networks. Out here in the technical service sector, we are seeing a major disconnect between executive innovation goals and baseline compliance reality.
Engineering teams are eager to use cutting-edge tools to speed up product lifecycles, but they frequently overlook how these tools interact with their underlying document repositories. If your business is moving forward without a formal AI readiness assessment for medical device operations, you are likely introducing severe, hidden compliance liabilities into an environment that demands absolute traceability.
Why Medical Device Manufacturers Have the Highest AI Stakes
In most consumer-facing industries, an unmanaged software tool is simply an IT headache or a minor data privacy risk. But in life sciences and medical device manufacturing, data decisions directly impact consumer safety and regulatory standing. Every document, revision history, and design file is a potentially auditable record.
When you introduce intelligent agents or Large Language Models (LLMs) into an active operation, they read, analyze, and synthesize data across your entire repository. If an agent is trained on proprietary manufacturing specs, quality management datasets, or clinical trials, it suddenly becomes part of your product’s lifecycle history. This creates a strict burden of proof for data traceability.
Furthermore, shadow AI in medical device manufacturing is almost certainly happening inside your organization right now. Brilliant design engineers and quality analysts are natural problem solvers. If they encounter a complex data set or a lengthy regulatory standard, they often copy and paste that text into free, unapproved web tools to generate summaries or draft code.
The point that compliance leaders must realize is simple: the FDA does not need to issue a brand-new, AI-specific regulation to penalize your organization. Existing data integrity frameworks are more than broad enough to capture these unmanaged configurations as severe audit findings.
What the FDA Looks for That AI Readiness Affects
To understand the true scale of FDA AI audit risk, you must look at how current regulatory standards map directly to automated data processing. The regulatory bodies are not waiting for the future; they are actively evaluating how software impacts patient safety today. According to the FDA’s official guidance on Software as a Medical Device (SaMD), electronic data integrity is a non-negotiable cornerstone of public safety.
When an inspector or a vendor due diligence team evaluates your system configuration, they look closely at three established operational areas that are heavily disrupted by unguided AI deployment:
21 CFR Part 11: Electronic Records and Audit Trails
This regulation mandates that electronic records must be trustworthy, reliable, and completely reviewable. Every modification, deletion, or system access event must generate an immutable, time-stamped audit trail. If an AI agent reads a document, modifies a configuration file, or pulls data to answer an engineer’s prompt, that automated interaction must be captured in your logs. If your tenant doesn’t generate reviewable logs for AI activities, you are in direct violation of Part 11.
Design Controls and Traceability
Under FDA frameworks, if software or automated workflows assist in making product design decisions, the underlying decision-making process must be fully documented and reproducible. If an engineer uses a cognitive tool to evaluate stress-test tolerances or material properties, you must be able to prove exactly what data source the AI used to arrive at its recommendation.
Corrective and Preventive Action (CAPA) Records
If an AI tool is deployed to scan your quality management data to surface recurring defect patterns, those automated findings must tie directly into your formal CAPA workflows. You cannot have an unmanaged AI engine flagging quality anomalies on a hidden corporate dashboard without a traceable, auditable path showing how the operations team evaluated and resolved those specific alerts.
ISO 27001 and QMS Alignment
Beyond direct FDA oversight, medical device builders face an onslaught of complex vendor and supplier security questionnaires. Major healthcare networks and global distributors want to verify that your digital infrastructure is genuinely hardened. Achieving an ISO 27001 medical device framework alignment is rapidly becoming the universal baseline required to pass these third-party reviews, proving that your quality management system (QMS) extends deep into your cloud security architecture.
The Microsoft 365 Tenant Is Where the Risk Lives
When executives envision an AI deployment, they often picture a sterile, sandboxed environment managed entirely by data scientists. But in practical day-to-day operations, the real risk lives inside your standard Microsoft 365 (M365) tenant.
Most medical device manufacturers store their active design files, component schemas, quality records, and clinical trial results directly inside everyday tools like SharePoint libraries and OneDrive folders.
When tools like Microsoft 365 Copilot are enabled—or when third-party browser extensions hook into corporate data—they do not operate in a vacuum. These agents access your records using inherited permissions. If your global tenant has “permission bloat,” where a design engineer has read access to sensitive clinical trial results or regulatory submission drafts they don’t need for their daily job, the AI will index that information instantly.
An AI readiness gap in your M365 environment is a direct data integrity failure. If an automated system can easily surface restricted or unverified quality data to the wrong user profiles, your underlying infrastructure fails to meet the basic access control parameters enforced by modern regulatory standards.
What a Professional AI Readiness Assessment Covers
You cannot fix or secure an infrastructure gap that your quality team hasn’t explicitly measured. This is exactly why we champion a proactive, scan-first approach at Cocha Technology. Rather than relying on guesswork or assuming your cloud environment matches your written policies, you must systematically evaluate your technical foundation.
Our comprehensive evaluation methodology is designed to give compliance and IT leaders total visibility before their next formal inspection occurs.
The assessment provides five concrete technical deliverables:
- Sanctioned and Shadow AI Inventory: We discover exactly which automated tools your engineers and analysts are visiting by running deep network communication scans.
- M365 Permission Audit for AI-Accessible Data: We identify areas of “excessive access,” pinpointing exactly which folders containing sensitive quality records are sitting open to unauthorized automated discovery.
- Audit Trail and Part 11 Coverage Analysis: We verify that your current diagnostic configurations are actively capturing and saving automated interaction logs in a reviewable format.
- ISO 27001 Control Alignment Mapping: We map your access controls, data asset registries, and risk tracking systems against global data security standards.
- Prioritized Technical Remediation Roadmap: You receive a step-by-step engineering plan detailing exactly which folders to restrict and which logging parameters to enable to ensure full compliance before your next regulatory audit.
For manufacturing leaders who want to ensure their entire corporate network is resilient against external threats, this validation fits perfectly alongside a broader exposure snapshot review, giving your operational team a clear, verifiable view of your complete data perimeter.
Protect Your Compliance Foundation
The adoption of artificial intelligence represents an incredible frontier for the future of healthcare and data analysis, providing manufacturers with the speed needed to bring life-saving technologies to market faster than ever before. But true operational excellence requires ensuring that your digital speed never bypasses your regulatory controls.
By executing a targeted data check, you protect your business from catastrophic compliance findings. You ensure that when you launch advanced internal agents, they operate safely inside strict, pre-hardened technical boundaries. Steve and the engineering team at Cocha Technology are ready to help you analyze your tenant rules, eliminate hidden data vulnerabilities, and construct a highly compliant environment that stands up to the closest regulatory scrutiny.
Harden Your Compliance Posture
Don’t wait for an unexpected inspection to show you where your automated tools are creating liabilities. Contact us today to schedule your formal AI Readiness Assessment and guarantee your cloud data remains fully protected and auditable.
Request Your Cocha Technology AI Readiness Assessment Today.
Recent Posts
Have Any Question?
Call or email Cocha. We can help with your cybersecurity needs!
- (281) 607-0616
- info@cochatechnology.com
About the Author:
Steve Combs
Co-Founder & Managing Director, Cocha Technology
Steven is a fractional CIO/CISO with 30+ years of enterprise IT and security leadership. He has built AI governance frameworks for organizations with 1,700+ users, led enterprise Microsoft Copilot deployments, and conducted security assessments across law firms, energy companies, financial institutions, and PE-backed manufacturers.